| Similar Articles |
|---|
 |
The Motley Fool
April 12, 2011
Sean Williams |
This Deal May Be Doomed From the Start See why Level 3's purchase of Global Crossing might be set up to fail.   |
Chemistry World
September 2, 2013
Emma Stoye |
Endo Health to buy Boca Pharmacal for $225m US speciality healthcare company Endo Health Solutions has agreed to buy Boca Pharmacal for $225 million in a bid to expand its generics business. |
Chemistry World
May 26, 2015
Phillip Broadwith |
Endo to buy Par as generics consolidation continues Irish-headquartered firm Endo Pharmaceuticals has agreed to buy private US firm Par Pharmaceuticals in a deal worth around $8 billion in a combination of cash, shares and assumed debt. |
Sports Illustrated
May 15, 2001
Rick Reilly |
Family Feud Bill Laurie owns the St. Louis Blues, one of the best teams in hockey this season. Pretty cool, yes? Ought to get you some strokes at family picnics, right? Unfortunately for Bill, his brother-in-law, Stan Kroenke, owns the Colorado Avalanche, the best team in the regular season... |
The Motley Fool
August 7, 2008
David Lee Smith |
Vale's Shining Ever Brighter A quick look at the quarterly results of Brazil's Vale indicates that the world's biggest iron ore producer's shine is only likely to brighten. |
The Motley Fool
January 10, 2007
Brian Lawler |
Endo's Plan to Bring In the Dough Despite little movement in the value of their shares, 2006 was an eventful year for investors in drug developer Endo Pharmaceuticals. |
The Motley Fool
April 30, 2008
Brian Lawler |
The Start of a New Endo The drugmaker marks its first quarter under new management. |
